← All terms
CATEGORY: REGULATORY PATHWAYS

Shonin (Japan Pre-Market Approval)

The PMDA/MHLW pre-market approval pathway for Class II (without standard), III, and IV medical devices in Japan. Shonin involves PMDA scientific review followed by MHLW formal approval.

Last reviewed 2026-08-05 · Reviewed by MedFlux Editorial Board · Editorial policy

WHEN IT APPLIES

Shonin is Japan’s PMDA/MHLW pre-market approval path for higher-risk devices (typically Class III/IV and some Class II without standards).

PROCESS / STEPS

  1. Confirm Japanese classification and pathway (Shonin vs Ninsho vs Todokede).
  2. Engage a DMAL holder.
  3. Prepare dossier and consult PMDA as needed.
  4. Complete review and MHLW authorization; plan PMS.

EXAMPLES

  • A novel implant without a certification standard typically requires Shonin rather than Ninsho.

RELATED GUIDES & TOOLS

SOURCES

Track regulatory signals related to Shonin (Japan Pre-Market Approval) across 27 authorities in real time.

START FREE →